Exactsciences.com

Oncotype DX® Exact Sciences

WebOncotype DX® | Exact Sciences. Exact Sciences is changing the way we think about treating cancer and is committed to providing life-changing treatment guidance for …

Actived: 8 days ago

URL: https://www.exactsciences.com/Our-Tests/Oncotype

Health Equity Exact Sciences

WebHealth Equity. Across the nation, gaps in health are large, persistent, and increasing. Many of these gaps result from system-driven barriers that prevent some people from getting …

Category: Health Go Health

Rick Baehner Exact Sciences

WebRick Baehner has served as our Chief Medical Officer, Precision Oncology since Exact Sciences’ acquisition of Genomic Health in November 2019. Rick joined Genomic …

Category: Medical Go Health

Costs & Coverage Precision Oncology

WebLet the Exact Sciences Customer Service group help you with Medicare coverage, private insurance coverage, and financial assistance. 888-662-6897. Learn about our insurance …

Category: Health Go Health

Home Precision Oncology

WebDiscover the Precision Oncology portfolio of genomic tests from Exact Sciences, which delivers actionable insights for breast, prostate, colon, and other solid tumors.

Category: Health Go Health

Exact Sciences Provider Hub

WebExact Sciences GPP is a portal for providers who use Exact Sciences' innovative tests for cancer screening and diagnosis. You can order tests, view results, manage accounts, …

Category: Cancer Go Health

Oncotype DX DCIS Score® Test │ Precision Oncology

WebAfter a diagnosis of non-invasive stage 0 breast cancer (called ductal carcinoma in situ [DCIS]), you and your doctor will need to determine the next steps in your treatment. The …

Category: Cancer Go Health

Our Expertise Multi-cancer early detection Exact Sciences

WebA fundamentally new approach to cancer screening 3. When used alongside single-organ standard-of-care cancer screenings, such as breast and colorectal cancer screenings, …

Category: Cancer Go Health

Oncotype DX Colon Recurrence Score ® test

WebThe Oncotype DX Colon Recurrence Score test is clinically validated to quantify the risk of recurrence of patients with anatomic stage II, T3 or T4, MMR-P, or stage III A/B colon …

Category: Health Go Health

Exact Sciences to Provide Mayo Clinic Patients with Individualized

WebInitiative advances precision cancer medicine by bringing comprehensive genomic profiling and hereditary cancer tests to patients at the Mayo Clinic …

Category: Cancer, Medicine Go Health

Exact Sciences Patient Hub

WebExact Sciences Patient Hub is a secure and convenient website that allows you to view your test results, track your order status, and manage your account. Whether you are using …

Category: Health Go Health

Oncotype DX Breast Recurrence Score® Test│ Precision Oncology

WebThe only test proven to predict likelihood of chemotherapy benefit 1,2. Provides a Recurrence Score ® result, which assesses the expression of 21 genes—16 cancer …

Category: Cancer Go Health

Exact Sciences And Genomic Health To Combine, Creating Leading …

WebJoins two of the strongest brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth; Forms best-in-class …

Category: Cancer Go Health

Breast Cancer │ Precision Oncology

WebSimply request a specimen kit to submit a sample by calling +1 866-ONCOTYPE ( +1 866-662-6897) prior to completing a requisition form on the portal. Once you order, we then …

Category: Health Go Health

EXACT SCIENCES LAUNCHES RISKGUARD™ HEREDITARY CANCER …

WebMADISON, Wis., February 28, 2024 – Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the launch of the Riskguard™ …

Category: Cancer Go Health

Insurance Coverage & Billing │ Precision Oncology

WebInsurance Coverage. The Oncotype ® and OncoExTra ® tests are covered by Medicare and many commercial insurance plans and available to patients who are enrolled in a …

Category: Health Go Health

Exact Sciences Launches OncoExTra Cancer Therapy Selection Test …

WebMADISON, Wis., February 7, 2023 – Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch of the …

Category: Cancer Go Health

Genomic Prostate Score® Result Explorer Precision Oncology

WebThis patient’s likelihood of adverse pathology (higher Gleason Score and/or extraprostatic disease (f)) at radical prostatectomy is 7% (95% CI: 4% - 14%) based on the combined …

Category: Health Go Health